Dialco Medical Inc. is a wholly owned subsidiary of Spectral Medical Inc. Founded in March 2019, Dialco is focused on the commercial development of SAMI, its proprietary renal replacement machine (approved for sale by Health Canada and cleared by the FDA). 

Dialco is attuned to the recent trends in the home hemodialysis (HHD) market and is actively working towards the regulatory development of its HHD machine called DIMI. Dialco is looking forward to serving the North American dialysis market.